News Daily News Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI Todd Neale May 11, 2015
News Industry News Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients May 07, 2015
News Daily News Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone L.A. McKeown April 28, 2015
News Daily News Meta-analyses Shed Light on the Impact of DAPT Duration Caitlin E. Cox April 03, 2015
News Daily News Real-World Study Supports Fondaparinux Over Heparin for NSTEMI Todd Neale February 22, 2015
News Daily News Year in Review: Physicians Highlight the Most Important Interventional News of 2014 Todd Neale January 12, 2015
News Features Despite New Findings, Optimal DAPT Duration Still Up in the Air Todd Neale December 10, 2014
News Daily News Meta-analysis Questions One-Size-Fits-All Anticoagulant Strategy in STEMI Patients L.A. McKeown November 17, 2014
News Daily News Meta-analysis: No Need for Thienopyridine Loading Dose in NSTE-ACS Patients Caitlin E. Cox November 17, 2014
News Conference News AHA 2014 Ezetimibe Proves Clinical Benefit on Top of Statin Therapy November 16, 2014
News Conference News AHA 2014 DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation Yael L. Maxwell November 16, 2014
News Conference News AHA 2014 ITALIC Shows Noninferiority of 6-Month DAPT in Good Aspirin Responders Yael L. Maxwell November 15, 2014
News Daily News Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients October 10, 2014
News Conference News TCT 2014 Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI September 13, 2014
News Daily News Meta-Analysis: Worse Clinical Outcomes But Less Bleeding With Bivalirudin in PCI Todd Neale August 20, 2014
News Daily News ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention Caitlin E. Cox April 11, 2014
News Conference News ACC 2014 ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients Caitlin E. Cox April 02, 2014
News Conference News ACC 2014 ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates Yael L. Maxwell March 31, 2014
News Daily News FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications Yael L. Maxwell February 13, 2014